Search clinical trials for: Developmental Spelling Disorder

Total 148133 results

Titan Pharmaceuticals

Terminated

A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia

Lymphoma, Small Lymphocytic | Leukemia, Lymphocytic, Chronic

United States
Radboud University Medical Center
Dutch Dairy Organization (NZO)

Completed

The STOVITA Study - Bioefficacy of Beta-Carotene in Oil and in a Mixed Diet in Ileostomy Patients

Healthy | Ileostomy

Netherlands
Stanford University
The Health Trust of Santa Clara County

Completed

Heart Disease on the Mend

Stroke | Hypertension | Coronary Heart Disease | Hyperlipidemia

United States
Catholic University of the Sacred Heart
Fondazione Telethon

Unknown

RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy

Myotonic Dystrophy | Sudden Cardiac Death

Italy
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Early Tracheotomy Versus Prolonged Endotracheal Intubation in Intensive Care Unit (ICU) Patients

Respiratory Insufficiency

France
Piyavate Hospital
T.C Union Global Plc.

Completed

Effect of Glutathione on Blood Alcohol and Hangover Symptoms

Alcohol Drinking

Thailand
Medical Benefits Fund of Australia

Completed

Evaluation of an Individualised Written Education Package for Stroke Patients

Stroke

Australia
East Valley Hematology and Oncology Medical Group
Astex Pharmaceuticals, Inc.; Pharmatech Oncology; Mena, Raul, M.D.

Unknown

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Chronic Lymphocytic Leukemia

United States
National Heart and Lung Institute
Wexham Park Hospital; 4th Military Hospital

Unknown

Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure

Heart Diseases | Anemia, Iron-Deficiency | Chronic Heart Failure

Poland, United Kingdom
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Combination Tablet Feasibility - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
French National Agency for Research on AIDS and...
Hoffmann-La Roche

Terminated

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma

AIDS Related Lymphoma

France
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Methadone/Buprenorphine Cross-Over Study - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
Profess Medical Consultancy

Completed

Study With Migraid Device in Acute, Early Treatment of Migraine With Typical Aura

Migraine With Typical Aura

Netherlands
Universitätsklinikum Hamburg-Eppendorf

Completed

Metyrapone as Additive Treatment in Major Depression

Major Depressive Disorder

Germany
University of Southern Denmark
Pfizer

Completed

Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)

Type 2 Diabetes Mellitus

Denmark
Repligen Corporation

Completed

Synthetic Human Secretin in Children With Autism

Autism

United States
Royal Brompton & Harefield NHS Foundation Trust
GlaxoSmithKline; CORDA, The Heart Charity

Unknown

Rosiglitazone Plaque Study

Vascular Diseases | Hypertension | Diabetes Mellitus, Type 2

United Kingdom
Erasmus Medical Center

Completed

A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer

Erectile Dysfunction | Prostate Cancer

Netherlands
University of Oxford
Wyeth is now a wholly owned subsidiary of Pfizer; Pfizer

Completed

An Evaluation of the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression

Depression

United Kingdom
Connor, Kathryn M., M.D.
Forest Laboratories

Completed

Study of Escitalopram in the Treatment of Specific Phobia

Phobic Disorders

United States
University of Sydney
National Health and Medical Research Council, Australia; Sydney South West... and other collaborators

Unknown

Trial for the Treatment of Alcohol Dependence

Alcoholism

Australia
National Center for Research Resources (NCRR)
Children's National Research Institute

Completed

A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)

Muscular Dystrophy, Duchenne

United States
Sandoz

Completed

A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

HIV Infections | Cytopenias

United States
Eunice Kennedy Shriver National Institute of Child...

Completed

Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation

Akathisia

United States
National Institute of Mental Health (NIMH)
Icahn School of Medicine at Mount Sinai

Completed

Study of Fluoxetine in Patients With Depersonalization Disorder

Depersonalization Disorder

United States
Corixa Corporation
GlaxoSmithKline

Unknown

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United Kingdom, United States
National Center for Research Resources (NCRR)
Oregon Health and Science University

Unknown

Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis

Cerebrotendinous Xanthomatosis

United States
Eunice Kennedy Shriver National Institute of Child...

Unknown

Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome

MELAS Syndrome

United States
National Center for Research Resources (NCRR)
James Whitcomb Riley Hospital for Children

Completed

Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes

Thrombocytopenia | Dyskeratosis Congenita | Fanconi's Anemia | Shwachman Syndrome
Icahn School of Medicine at Mount Sinai

Completed

Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope

Syncope

United States
Centaur Pharmaceuticals

Completed

Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy

HIV Infections | AIDS Dementia Complex

United States
National Center for Research Resources (NCRR)
University of Pennsylvania

Completed

Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia

Familial Hypercholesterolemia
Amgen

Completed

A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.

HIV Infections | Cytopenias

United States, Canada
National Center for Research Resources (NCRR)

Completed

A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)

Diabetes Mellitus | Insulin Resistance

United States
Glaxo Wellcome

Completed

A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications

HIV Infections

United States
Eunice Kennedy Shriver National Institute of Child...
National Institute of Mental Health (NIMH)

Completed

Improving Mental Health Services for Economically Disadvantaged Children: Training Teachers

Psychopathology

United States
National Center for Research Resources (NCRR)
University of Pittsburgh

Unknown

Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease

Gaucher's Disease

United States
National Center for Research Resources (NCRR)
Children's Hospital Medical Center, Cincinnati

Unknown

Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation

Intrauterine Growth Retardation

United States
Eunice Kennedy Shriver National Institute of Child...

Unknown

Magnesium Sulfate to Prevent Brain Injury in Premature Infants

Cerebral Palsy | Brain Injuries

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Behavior and Naltrexone Treatment for Alcoholics

Alcoholism

United States
National Center for Research Resources (NCRR)
Mayo Clinic

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
National Center for Research Resources (NCRR)
Baylor College of Medicine

Unknown

Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head Injuries

Head Injuries, Closed

United States, Canada

Search clinical trials for: Developmental Spelling Disorder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations